| Literature DB >> 35011877 |
David Stuart Kitchen1,2, Jack Richards2, Peter J Smitham1,2, Gerald J Atkins1, Lucian B Solomon1,2.
Abstract
Surgical management of displaced tibial plateau fracture (TPF) is often delayed due to accompanying soft tissue injuries sustained at the time of injury. The primary aim of this study was to assess the effect of time to surgery on fracture reduction in cases of TPF. The secondary aim was to assess the effect of preoperative demographics and residual articular step on Lysholm Scores and Knee Injury and Osteoarthritis Outcome Scores (KOOS) following fixation. Patients between 2006 and 2017, managed by a single surgeon, were prospectively enrolled in the study. Reduction of articular step, defined as <2 mm, was assessed by a single blinded examiner. A total of 117 patients were enrolled, 52 with Schatzker II, 4 with Schatzker IV, and 61 with Schatzker VI fractures. Patients were followed up to a mean of 3.9 years. Analysis showed that the ability to achieve fracture reduction was negatively influenced by time to theatre, with the odds of achieving reduction decreasing 17% with each subsequent day post injury (p = 0.002). Furthermore, an increased time to theatre was associated with a reduced Lysholm score at one year (p = 0.01). The ability to achieve fracture reduction did not influence PROMs within the study period. We conclude that delay in surgical fixation negatively affects fracture reduction in TPF and may delay recovery. However, residual articular step does not necessarily influence PROMs over the mid-term.Entities:
Keywords: articular step; fracture fixation; fracture reduction; patient-reported outcome; tibial plateau fracture
Year: 2021 PMID: 35011877 PMCID: PMC8745337 DOI: 10.3390/jcm11010138
Source DB: PubMed Journal: J Clin Med ISSN: 2077-0383 Impact factor: 4.241
Figure 1Preoperative AP (a) and lateral (b) with postoperative Day 2 AP (c) and lateral (d) radiographs of a reduced tibial plateau fracture (Schatzker II) in a patient without medical comorbidities.
Figure 2Pre- (a) and postoperative Day 2 (b) AP radiographs of a fracture that was not reduced (Schatzker VI) in a patient with Marfan syndrome. Note that the articular step is better visible on the lateral views (c,d). (e,f) Lateral and AP radiographs of the same fracture 5 years after injury following removal of the anterolateral plate and screws (removal of metalwork 21 months post primary surgery). Note the residual articular step and secondary degenerative changes. Despite fracture malreduction, the 5-year Lysholm score, KOOS pain score, and KOOS quality of life score were 80, 94.4, and 68.6, respectively.
Patient demographics and their relationship to time to theatre.
| Demographic | Subcategory | Value (Range) | Mean Time to Theatre (SD, Range) | |
|---|---|---|---|---|
| Age (years) | 45.4 (21–78) | 0.388 | ||
| Male | 74 | 6.4 (5.0, 0–26) | 0.129 | |
| Female | 43 | 5.1 (3.5, 1–19) | ||
| Smoking status | Smoker | 25 | 7.1 (5.1, 1–26) | 0.114 |
| Nonsmoker | 92 | 5.6 (4.3, 0–24) | ||
| Diabetes status | Diabetic | 5 | 3.4 (1.9, 2–6) | 0.202 |
| Nondiabetic | 112 | 6.1 (4.6, 0–26) | ||
| I | 0 | 0.627 | ||
| II | 52 | 6.0 (4.7, 0–24) | ||
| III | 0 | |||
| IV | 4 | 3.8 (2.2, 1–6) | ||
| V | 0 | |||
| VI | 61 | 6.0 (4.6, 1–26) | ||
| Mechanism of injury | Low energy | 39 | 6.0 (5.1, 2–24) | 0.911 |
| High energy | 78 | 5.9 (4.3, 0–26) | ||
| Preoperative articular step (mm) | 8.1 (0.5–54) | 0.009 | ||
| Time to theatre | 5.9 (0–26) |
Patient demographics and their relationship to fracture reduction.
| Demographic | Reduced | Unreduced | ||
|---|---|---|---|---|
| Age (years) | 46.7 (21–78) | 43.9 (24–74) | 0.316 | |
| Sex | Male | 44 | 30 | 0.058 |
| Female | 33 | 10 | ||
| Smoking status | Smoker | 13 | 12 | 0.102 |
| Nonsmoker | 64 | 28 | ||
| Diabetic status | Diabetic | 4 | 1 | 0.498 |
| Nondiabetic | 73 | 39 | ||
| Schatzker type | II | 38 | 14 | 0.077 |
| IV | 4 | 0 | ||
| VI | 35 | 26 | ||
| Mechanism of injury | Low energy | 30 | 9 | 0.074 |
| High energy | 47 | 31 | ||
| Preoperative articular step (mm) | 7.57 (0.5–43) | 9.11 (1–54) | 0.344 | |
| Mean number of plates used for fixation | 1.56 (0–3) | 1.84 (0–5) | 0.166 | |
| Bone graft used | 48 | 24 | 0.848 |
Association between time to theatre and fracture reduction.
| Exposure | Adjusted OR (95% CI) | ||
|---|---|---|---|
| Time to theatre | Days | 0.83 (0.74, 0.93) | 0.002 |
| Age | 1.03 (0.99, 1.06) | 0.127 | |
| Sex | Male | 0.64 (0.21, 1.98) | 0.437 |
| Female | Reference | ||
| Smoking status | Smoker | 0.46 (0.16, 1.39) | 0.170 |
| Nonsmoker | Reference | ||
| Diabetes status | Diabetic | 0.64 (0.05, 7.64) | 0.722 |
| Nondiabetic | Reference | ||
| Schatzker type | II | Reference | 0.168 |
| IV | * | ||
| VI | 0.48 (0.17, 1.36) | ||
| Mechanism of injury | Low energy | Reference | 0.173 |
| High energy | 0.48 (0.16, 1.38) | ||
| Preoperative articular step | 0.98 (0.92, 1.04) | 0.468 | |
* perfectly predicts fracture reduction, that is, all patients with Schatzker type IV had reduced fractures.
Patient-reported outcome scores in reduced and unreduced fracture patient cohorts.
| Reduced | Unreduced | ||
|---|---|---|---|
| 6-month Lysholm | 68.1 (30–100) | 62.8 (8–92) | 0.298 |
| 6-month KOOS pain | 75.0 (41–100) | 69.8 (21–94) | 0.230 |
| 6-month KOOS QOL | 48.9 (6–100) | 41.2 (6–94) | 0.151 |
| 1-year Lysholm | 70.3 (29–100) | 66.8 (23–100) | 0.438 |
| 1-year KOOS pain | 75.2 (39–100) | 76.1 (47–100) | 0.810 |
| 1-year KOOS QOL | 51.7 (0–100) | 52.3 (19–100) | 0.918 |
| Mid-term Lysholm | 73.0 (32–100) | 72.1 (34–99) | 0.875 |
| Mid-term KOOS pain | 81.6 (47–100) | 82.7 (42–100) | 0.801 |
| Mid-term KOOS QOL | 58.0 (6–100) | 62.8 (25–100) | 0.436 |
Patient-reported outcomes scores vs. fracture type (Schatzker classification).
| Schatzker II | Schatzker VI | ||
|---|---|---|---|
| 6-month Lysholm | 70.7 (8–100) | 60.7 (9–92) | 0.049 |
| 6-month KOOS pain | 74.1 (21–100) | 71.8 (34–97) | 0.600 |
| 6-month KOOS QOL | 51.1 (6–100) | 41.4 (6–94) | 0.067 |
| 1-year Lysholm | 70 (23–100) | 68.6 (29–100) | 0.745 |
| 1-year KOOS pain | 75.2 (42–100) | 75.4 (39–100) | 0.947 |
| 1-year KOOS QOL | 52.3 (19–100) | 50.2 (0–100) | 0.708 |
| Mid-term Lysholm | 72.6 (34–100) | 74.3 (32–99) | 0.734 |
| Mid-term KOOS pain | 84.5 (47–100) | 75.9 (56–100) | 0.105 |
| Mid-term KOOS QOL | 60.2 (6–100) | 51.0 (19–100) | 0.314 |
Figure 3Effect of time to theatre on patient-reported outcome score. Lysholm score at (a) 6 months, (b) 12 months, and (c) medium term. KOOS Pain at (d) 6 months, (e) 12 months, and (f) medium term. KOOS QOL at (g) 6 months, (h) 12 months, and (i) medium term. Spearman correlation coefficients with respective confidence intervals are reported for each image.